Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Glycosylated Atrial Natriuretic Peptide on Blood Pressure and Fluid Balance in Healthy Volunteers

NCT07606183 is registered in ClinicalTrials.gov with Peter Fruergaard Andersen as lead sponsor.

NCT NCT07606183
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07606183 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Glycosylated Atrial Natriuretic Peptide on Blood Pressure and Fluid Balance in Healthy Volunteers
Lead sponsor
Peter Fruergaard Andersen
Phase
Phase 1
Overall status
Completed
Start date
May 1, 2022
Completion date
March 30, 2026
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, hypertension, kidney failure